PLx Pharma Inc.
PLXP · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,497 | -$11,858 | -$10,785 | $3,562 |
| Dep. & Amort. | $58 | $49 | $56 | $55 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,107 | $1,050 | $1,088 | $0 |
| Change in WC | -$2,326 | -$5,001 | $156 | $6,420 |
| Other Non-Cash | -$1,324 | -$2,339 | -$7,408 | -$24,411 |
| Operating Cash Flow | -$10,982 | -$18,099 | -$16,893 | -$13,361 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,086 | $1,330 | $0 | $24 |
| Stock Repurch. | $0 | $0 | $0 | $8,660 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,086 | $1,330 | $0 | $198 |
| Financing Cash Flow | $1,086 | $1,330 | $0 | $198 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9,896 | -$16,769 | -$16,893 | -$13,162 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,730 | $52,499 | $69,392 | $82,554 |
| End Cash | $25,834 | $35,730 | $52,499 | $69,392 |
| Free Cash Flow | -$10,982 | -$18,099 | -$16,893 | -$13,361 |